# Pediatric Clinical Research Quality Management System This repository contains template documents for implementing a Quality Management System (QMS) specifically designed for **Pediatric Clinical Research**, with focus on the unique regulatory, ethical, and operational requirements for research involving children. ## Designed For - Pediatric Clinical Research Organizations (CROs) - Children's Hospitals and Academic Medical Centers - Pediatric Clinical Trial Sites - Pharmaceutical/Biotech Pediatric Development Programs - Pediatric Research Networks - IRB/Ethics Committees reviewing pediatric research ## Repository Structure ``` pediatric-clinical-research/ ├── Policies/ # Quality policies and management commitment ├── SOPs/ # Standard Operating Procedures │ ├── Clinical/ # Clinical trial operations │ ├── Regulatory/ # Regulatory submissions and compliance │ ├── Data-Management/ # Clinical data handling │ ├── Safety/ # Adverse event reporting │ └── Pediatric-Specific/ # Pediatric-specific procedures ├── Work Instructions/ # Detailed work instructions ├── Forms/ # Record forms and templates │ ├── Assent-Forms/ # Age-appropriate assent templates │ ├── Parental-Permission/ # Parental permission templates │ ├── Case-Report/ # Pediatric CRF templates │ ├── Monitoring/ # Site monitoring forms │ └── Safety-Monitoring/ # Pediatric safety monitoring └── Templates/ # Document templates ``` ## Document Numbering Convention - **POL-XXX**: Policies - **SOP-CL-XXX**: Clinical SOPs - **SOP-REG-XXX**: Regulatory SOPs - **SOP-DM-XXX**: Data Management SOPs - **SOP-SAF-XXX**: Safety SOPs - **SOP-PED-XXX**: Pediatric-Specific SOPs - **WI-XXX**: Work Instructions - **FRM-XXX**: Forms and Records - **ASF-XXX**: Assent Forms - **PPF-XXX**: Parental Permission Forms - **ICF-XXX**: Informed Consent Forms (for parents/LAR) ## AI-Powered Document Creation This template includes **AtomicAI** integration specialized for pediatric research. Simply create an issue and mention `@atomicai` to: - Generate pediatric-specific SOPs - Create age-appropriate assent forms - Draft parental permission documents - Develop pediatric safety monitoring plans - Update existing documents with pediatric considerations ## Getting Started 1. Create a new repository using this template 2. Customize documents with your organization's information 3. Create issues with `@atomicai` to generate new pediatric research documents 4. Review and approve AI-generated content via Pull Requests ## Pediatric Age Classifications This template uses standard pediatric age classifications: | Age Group | Definition | |-----------|------------| | **Neonates** | Birth to 28 days | | **Infants** | 29 days to < 2 years | | **Children** | 2 to < 12 years | | **Adolescents** | 12 to < 18 years (or < 21 in some jurisdictions) | ## Key Pediatric Research Considerations ### Ethical Protections - **45 CFR 46 Subpart D**: Additional protections for children in research - **21 CFR 50 Subpart D**: Additional safeguards for children - Both parental permission AND child assent typically required - Minimal risk threshold assessed differently for pediatric population - Direct benefit to child must be clearly articulated ### Regulatory Frameworks - **ICH E11**: Clinical Investigation of Medicinal Products in the Pediatric Population - **Pediatric Research Equity Act (PREA)**: Requires pediatric studies for certain new drugs/biologics - **Best Pharmaceuticals for Children Act (BPCA)**: Incentivizes pediatric drug studies - **FDA Pediatric Study Plans (PSP)**: Required planning documents for pediatric investigations ### Operational Considerations - Age-appropriate assent processes and materials - Parental permission requirements (one vs. two parents) - School/education coordination for study visits - Growth and development monitoring - Pediatric dosing and pharmacokinetics - Adolescent-specific issues (emancipated minors, reproductive health) - Family-centered care approaches - Minimizing caregiver burden ### Safety Monitoring - Enhanced safety monitoring requirements - Growth and development assessments - Long-term follow-up considerations - Pediatric-specific adverse events - Data Safety Monitoring Board (DSMB) requirements - Expedited reporting timelines ## Regulatory Compliance These templates support compliance with: - **45 CFR 46 Subpart D** - Additional Protections for Children - **21 CFR Part 50 Subpart D** - Additional Safeguards for Children - **ICH-GCP E6(R2)** - Good Clinical Practice - **ICH E11** - Pediatric Clinical Investigations - **21 CFR Part 11** - Electronic Records - **21 CFR Parts 50, 56** - Human Subject Protection - **HIPAA** - Health Information Privacy - **COPPA** - Children's Online Privacy Protection Act (if applicable) - **GDPR** - Data Protection (EU studies) ## Special Populations This template addresses: - Neonatal intensive care research - Pediatric oncology studies - Rare pediatric diseases - Emergency research in children - Genetic/genomic research in pediatrics - Mental health research with minors - Adolescent reproductive health research --- *Powered by AtomicQMS - AI-Enhanced Pediatric Clinical Research Quality Management*